Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: A report from the International DLBCL Rituximab-CHOP Consortium Program Academic Article uri icon

Overview

MeSH Major

  • Cyclin D1
  • Lymphoma, Large B-Cell, Diffuse
  • Lymphoma, Mantle-Cell

abstract

  • Compared with patients who had cyclin D1-negative DLBCL, men were more commonly affected with cyclin D1-positive DLBCL, and they were significantly younger. There were no other significant differences in clinical presentation, pathologic features, overall survival, or progression-free survival between these two subgroups of patients with DLBCL.

publication date

  • June 15, 2014

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.28664

PubMed ID

  • 24648050

Additional Document Info

start page

  • 1818

end page

  • 29

volume

  • 120

number

  • 12